We carry four peptide combinations on the shelf at Linden. Three of them earn their place. The fourth has been replaced quietly since the last field note.
The replacements come from a long internal review — patient outcomes at six, twelve, and twenty-four weeks. The literature, where it exists, agrees. Where it does not, we tend to side with our own clinical record.
If a recommendation here ever changes, we will say so plainly in the next field note. Nothing has ever been quietly removed.